{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T06:59:15Z","timestamp":1793775555002,"version":"4.6.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"7855","license":[{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2021,4,22]]},"DOI":"10.1038\/s41586-021-03324-6","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T17:27:28Z","timestamp":1612978048000},"page":"616-622","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1237,"title":["mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants"],"prefix":"10.1038","volume":"592","author":[{"given":"Zijun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiska","family":"Weisblum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0132-5101","authenticated-orcid":false,"given":"Frauke","family":"Muecksch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher O.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4474-2658","authenticated-orcid":false,"given":"Shlomo","family":"Finkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5380-2950","authenticated-orcid":false,"given":"Dennis","family":"Schaefer-Babajew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Cipolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7295-8128","authenticated-orcid":false,"given":"Christian","family":"Gaebler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna A.","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2654-0879","authenticated-orcid":false,"given":"Thiago Y.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan E.","family":"Abernathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn E.","family":"Huey-Tubman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene","family":"Hurley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9640-0559","authenticated-orcid":false,"given":"Martina","family":"Turroja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamille A.","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristie","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2247-3178","authenticated-orcid":false,"given":"Katrina G.","family":"Millard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7353-3420","authenticated-orcid":false,"given":"Victor","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6393-0000","authenticated-orcid":false,"given":"Justin","family":"Da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4154-4322","authenticated-orcid":false,"given":"Jianliang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Colbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshni","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Dizon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecille","family":"Unson-O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Shimeliovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Gazumyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1727-8693","authenticated-orcid":false,"given":"Marina","family":"Caskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2277-3990","authenticated-orcid":false,"given":"Pamela J.","family":"Bjorkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9282-2287","authenticated-orcid":false,"given":"Rafael","family":"Casellas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7889-0766","authenticated-orcid":false,"given":"Theodora","family":"Hatziioannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2368-3719","authenticated-orcid":false,"given":"Paul D.","family":"Bieniasz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0592-8564","authenticated-orcid":false,"given":"Michel C.","family":"Nussenzweig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,10]]},"reference":[{"key":"3324_CR1","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/d41586-020-02926-w","volume":"586","author":"C Gaebler","year":"2020","unstructured":"Gaebler, C. & Nussenzweig, M. C. All eyes on a hurdle race for a SARS-CoV-2 vaccine. Nature 586, 501\u2013502 (2020).","journal-title":"Nature"},{"key":"3324_CR2","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","volume":"383","author":"LA Jackson","year":"2020","unstructured":"Jackson, L. A. et al. An mRNA vaccine against SARS-CoV-2 \u2013 preliminary report. N. Engl. J. Med. 383, 1920\u20131931 (2020).","journal-title":"N. Engl. J. Med."},{"key":"3324_CR3","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/s41586-020-2798-3","volume":"586","author":"F Krammer","year":"2020","unstructured":"Krammer, F. SARS-CoV-2 vaccines in development. Nature 586, 516\u2013527 (2020).","journal-title":"Nature"},{"key":"3324_CR4","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N. Engl. J. Med. 383, 2603\u20132615 (2020).","journal-title":"N. Engl. J. Med."},{"key":"3324_CR5","doi-asserted-by":"publisher","unstructured":"Gaebler, C. et al. Evolution of antibody immunity to SARS-CoV-2. Nature, https:\/\/doi.org\/10.1038\/s41586-021-03207-w (2021).","DOI":"10.1038\/s41586-021-03207-w"},{"key":"3324_CR6","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41586-020-2456-9","volume":"584","author":"DF Robbiani","year":"2020","unstructured":"Robbiani, D. F. et al. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature 584, 437\u2013442 (2020).","journal-title":"Nature"},{"key":"3324_CR7","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41586-020-2852-1","volume":"588","author":"CO Barnes","year":"2020","unstructured":"Barnes, C. O. et al. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature 588, 682\u2013687 (2020).","journal-title":"Nature"},{"key":"3324_CR8","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.cell.2020.06.025","volume":"182","author":"CO Barnes","year":"2020","unstructured":"Barnes, C. O. et al. Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies. Cell 182, 828\u2013842 (2020).","journal-title":"Cell"},{"key":"3324_CR9","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1056\/NEJMoa2024671","volume":"383","author":"KS Corbett","year":"2020","unstructured":"Corbett, K. S. et al. Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates. N. Engl. J. Med. 383, 1544\u20131555 (2020).","journal-title":"N. Engl. J. Med."},{"key":"3324_CR10","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41586-020-2814-7","volume":"586","author":"U Sahin","year":"2020","unstructured":"Sahin, U. et al. COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses. Nature 586, 594\u2013599 (2020).","journal-title":"Nature"},{"key":"3324_CR11","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201181","volume":"217","author":"F Schmidt","year":"2020","unstructured":"Schmidt, F. et al. Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses. J. Exp. Med. 217, e20201181 (2020).","journal-title":"J. Exp. Med."},{"key":"3324_CR12","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1056\/NEJMc2032195","volume":"384","author":"AT Widge","year":"2021","unstructured":"Widge, A. T. et al. Durability of responses after SARS-CoV-2 mRNA-1273 vaccination. N. Engl. J. Med. 384, 80\u201382 (2021).","journal-title":"N. Engl. J. Med."},{"key":"3324_CR13","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.61312","volume":"9","author":"Y Weisblum","year":"2020","unstructured":"Weisblum, Y. et al. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. eLife 9, e61312 (2020).","journal-title":"eLife"},{"key":"3324_CR14","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1126\/science.abd0831","volume":"369","author":"A Baum","year":"2020","unstructured":"Baum, A. et al. Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science 369, 1014\u20131018 (2020).","journal-title":"Science"},{"key":"3324_CR15","doi-asserted-by":"publisher","unstructured":"Davies, N. G. et al. Estimated transmissibility and severity of novel SARS-CoV-2 variant of concern 202012\/01 in England. Preprint at https:\/\/doi.org\/10.1101\/2020.12.24.20248822 (2020).","DOI":"10.1101\/2020.12.24.20248822"},{"key":"3324_CR16","doi-asserted-by":"publisher","unstructured":"Greaney, A. J. et al. Comprehensive mapping of mutations to the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human serum antibodies. Preprint at https:\/\/doi.org\/10.1101\/2020.12.31.425021 (2021).","DOI":"10.1101\/2020.12.31.425021"},{"key":"3324_CR17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.chom.2020.11.007","volume":"29","author":"AJ Greaney","year":"2021","unstructured":"Greaney, A. J. et al. Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition. Cell Host Microbe 29, 44\u201357 (2021).","journal-title":"Cell Host Microbe"},{"key":"3324_CR18","unstructured":"National Institute of Infectious Diseases. Brief report: new variant strain of SARS-CoV-2 identified in travelers from Brazil. https:\/\/www.niid.go.jp\/niid\/en\/2019-ncov-e\/10108-covid19-33-en.html (2021)."},{"key":"3324_CR19","doi-asserted-by":"publisher","unstructured":"Tegally, H. et al. Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa. Preprint at https:\/\/doi.org\/10.1101\/2020.12.21.20248640 (2020).","DOI":"10.1101\/2020.12.21.20248640"},{"key":"3324_CR20","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1001\/jama.2020.27124","volume":"325","author":"AS Lauring","year":"2021","unstructured":"Lauring, A. S. & Hodcroft, E. B. Genetic variants of SARS-CoV-2\u2013what do they mean? J. Am. Med. Assoc. 325, 529\u2013531 (2021).","journal-title":"J. Am. Med. Assoc."},{"key":"3324_CR21","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1056\/NEJMoa066092","volume":"357","author":"IJ Amanna","year":"2007","unstructured":"Amanna, I. J., Carlson, N. E. & Slifka, M. K. Duration of humoral immunity to common viral and vaccine antigens. N. Engl. J. Med. 357, 1903\u20131915 (2007).","journal-title":"N. Engl. J. Med."},{"key":"3324_CR22","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1126\/science.abc5902","volume":"369","author":"PJM Brouwer","year":"2020","unstructured":"Brouwer, P. J. M. et al. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. Science 369, 643\u2013650 (2020).","journal-title":"Science"},{"key":"3324_CR23","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cell.2020.05.025","volume":"182","author":"Y Cao","year":"2020","unstructured":"Cao, Y. et al. Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients\u2019 B cells. Cell 182, 73\u201384 (2020).","journal-title":"Cell"},{"key":"3324_CR24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41586-020-2380-z","volume":"584","author":"B Ju","year":"2020","unstructured":"Ju, B. et al. Human neutralizing antibodies elicited by SARS-CoV-2 infection. Nature 584, 115\u2013119 (2020).","journal-title":"Nature"},{"key":"3324_CR25","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41586-020-2571-7","volume":"584","author":"L Liu","year":"2020","unstructured":"Liu, L. et al. Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike. Nature 584, 450\u2013456 (2020).","journal-title":"Nature"},{"key":"3324_CR26","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1126\/science.abc7520","volume":"369","author":"TF Rogers","year":"2020","unstructured":"Rogers, T. F. et al. Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model. Science 369, 956\u2013963 (2020).","journal-title":"Science"},{"key":"3324_CR27","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/s41586-020-2548-6","volume":"584","author":"SJ Zost","year":"2020","unstructured":"Zost, S. J. et al. Potently neutralizing and protective human antibodies against SARS-CoV-2. Nature 584, 443\u2013449 (2020).","journal-title":"Nature"},{"key":"3324_CR28","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41586-019-0879-y","volume":"566","author":"B Briney","year":"2019","unstructured":"Briney, B., Inderbitzin, A., Joyce, C. & Burton, D. R. Commonality despite exceptional diversity in the baseline human antibody repertoire. Nature 566, 393\u2013397 (2019).","journal-title":"Nature"},{"key":"3324_CR29","doi-asserted-by":"publisher","unstructured":"Andreano, E. et al. SARS-CoV-2 escape in vitro from a highly neutralizing COVID-19 convalescent plasma. Preprint at https:\/\/doi.org\/10.1101\/2020.12.28.424451 (2020).","DOI":"10.1101\/2020.12.28.424451"},{"key":"3324_CR30","doi-asserted-by":"publisher","unstructured":"Thomson, E. C. et al. Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity. Cell, https:\/\/doi.org\/10.1016\/j.cell.2021.01.037 (2021).","DOI":"10.1016\/j.cell.2021.01.037"},{"key":"3324_CR31","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1126\/science.abe3354","volume":"370","author":"MA Tortorici","year":"2020","unstructured":"Tortorici, M. A. et al. Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms. Science 370, 950\u2013957 (2020).","journal-title":"Science"},{"key":"3324_CR32","doi-asserted-by":"crossref","unstructured":"Starr, T. N. et al. Prospective mapping of viral mutations that escape antibodies used to treat COVID-19. Science 371, 850\u2013854 (2021).","DOI":"10.1126\/science.abf9302"},{"key":"3324_CR33","doi-asserted-by":"publisher","unstructured":"Singer, J., Gifford, R., Cotten, M. & Robertson, D. CoV-GLUE: a web application for tracking SARS-CoV-2 genomic variation. Preprint at https:\/\/doi.org\/10.20944\/preprints202006.0225.v1 (2020).","DOI":"10.20944\/preprints202006.0225.v1"},{"key":"3324_CR34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/gch2.1018","volume":"1","author":"S Elbe","year":"2017","unstructured":"Elbe, S. & Buckland-Merrett, G. Data, disease and diplomacy: GISAID\u2019s innovative contribution to global health. Glob Chall. 1, 33\u201346 (2017).","journal-title":"Glob Chall."},{"key":"3324_CR35","doi-asserted-by":"publisher","unstructured":"Voloch, C. M. et al. Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil. Preprint at https:\/\/doi.org\/10.1101\/2020.12.23.20248598 (2020).","DOI":"10.1101\/2020.12.23.20248598"},{"key":"3324_CR36","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1126\/science.abd0826","volume":"369","author":"CL Hsieh","year":"2020","unstructured":"Hsieh, C. L. et al. Structure-based design of prefusion-stabilized SARS-CoV-2 spikes. Science 369, 1501\u20131505 (2020).","journal-title":"Science"},{"key":"3324_CR37","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41586-020-2665-2","volume":"588","author":"Z Ke","year":"2020","unstructured":"Ke, Z. et al. Structures and distributions of SARS-CoV-2 spike proteins on intact virions. Nature 588, 498\u2013502 (2020).","journal-title":"Nature"},{"key":"3324_CR38","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.cell.2020.09.037","volume":"183","author":"L Piccoli","year":"2020","unstructured":"Piccoli, L. et al. Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology. Cell 183, 1024\u20131042 (2020).","journal-title":"Cell"},{"key":"3324_CR39","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201993","volume":"218","author":"A Sch\u00e4fer","year":"2021","unstructured":"Sch\u00e4fer, A. et al. Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo. J. Exp. Med. 218, e20201993 (2021).","journal-title":"J. Exp. Med."},{"key":"3324_CR40","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41586-018-0531-2","volume":"561","author":"P Mendoza","year":"2018","unstructured":"Mendoza, P. et al. Combination therapy with anti-HIV-1 antibodies maintains viral suppression. Nature 561, 479\u2013484 (2018).","journal-title":"Nature"},{"key":"3324_CR41","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1038\/s41591-018-0186-4","volume":"24","author":"Y Bar-On","year":"2018","unstructured":"Bar-On, Y. et al. Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals. Nat. Med. 24, 1701\u20131707 (2018).","journal-title":"Nat. Med."},{"key":"3324_CR42","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41586-020-2349-y","volume":"583","author":"D Pinto","year":"2020","unstructured":"Pinto, D. et al. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature 583, 290\u2013295 (2020).","journal-title":"Nature"},{"key":"3324_CR43","doi-asserted-by":"publisher","unstructured":"Rappazzo, C. G. et al. An engineered antibody with broad protective efficacy in murine models of SARS and COVID-19. Preprint at https:\/\/doi.org\/10.1101\/2020.11.17.385500 (2020).","DOI":"10.1101\/2020.11.17.385500"},{"key":"3324_CR44","doi-asserted-by":"publisher","unstructured":"Cele, S. et al. Escape of SARS-CoV-2 501Y.V2 variants from neutralization by convalescent plasma. Preprint at https:\/\/doi.org\/10.1101\/2021.01.26.21250224 (2021).","DOI":"10.1101\/2021.01.26.21250224"},{"key":"3324_CR45","doi-asserted-by":"publisher","unstructured":"Wu, K. et al. mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants. Preprint at https:\/\/doi.org\/10.1101\/2021.01.25.427948 (2021).","DOI":"10.1101\/2021.01.25.427948"},{"key":"3324_CR46","doi-asserted-by":"publisher","unstructured":"Xie, X. et al. Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera. Preprint at https:\/\/doi.org\/10.1101\/2021.01.07.425740 (2021).","DOI":"10.1101\/2021.01.07.425740"},{"key":"3324_CR47","doi-asserted-by":"publisher","unstructured":"Wibmer, C. K. et al. SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma. Preprint at https:\/\/doi.org\/10.1101\/2021.01.18.427166 (2021).","DOI":"10.1101\/2021.01.18.427166"},{"key":"3324_CR48","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.cell.2020.07.012","volume":"182","author":"Q Li","year":"2020","unstructured":"Li, Q. et al. The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity. Cell 182, 1284\u20131294 (2020).","journal-title":"Cell"},{"key":"3324_CR49","doi-asserted-by":"publisher","unstructured":"Eguia, R. et al. A human coronavirus evolves antigenically to escape antibody immunity. Preprint at https:\/\/doi.org\/10.1101\/2020.12.17.423313 (2020).","DOI":"10.1101\/2020.12.17.423313"},{"key":"3324_CR50","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/s41591-020-0913-5","volume":"26","author":"F Amanat","year":"2020","unstructured":"Amanat, F. et al. A serological assay to detect SARS-CoV-2 seroconversion in humans. Nat. Med. 26, 1033\u20131036 (2020).","journal-title":"Nat. Med."},{"key":"3324_CR51","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","volume":"181","author":"A Grifoni","year":"2020","unstructured":"Grifoni, A. et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 181, 1489\u20131501 (2020).","journal-title":"Cell"},{"key":"3324_CR52","doi-asserted-by":"crossref","unstructured":"Cohen, A. A. et al. Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice. Science 371, 735\u2013741 (2021).","DOI":"10.1126\/science.abf6840"},{"key":"3324_CR53","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jsb.2005.07.007","volume":"152","author":"DN Mastronarde","year":"2005","unstructured":"Mastronarde, D. N. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 152, 36\u201351 (2005).","journal-title":"J. Struct. Biol."},{"key":"3324_CR54","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"3324_CR55","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/pro.3235","volume":"27","author":"TD Goddard","year":"2018","unstructured":"Goddard, T. D. et al. UCSF ChimeraX: meeting modern challenges in visualization and analysis. Protein Sci. 27, 14\u201325 (2018).","journal-title":"Protein Sci."},{"key":"3324_CR56","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/s41592-018-0173-1","volume":"15","author":"TC Terwilliger","year":"2018","unstructured":"Terwilliger, T. C., Adams, P. D., Afonine, P. V. & Sobolev, O. V. A fully automatic method yielding initial models from high-resolution cryo-electron microscopy maps. Nat. Methods 15, 905\u2013908 (2018).","journal-title":"Nat. Methods"},{"key":"3324_CR57","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D"},{"key":"3324_CR58","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1093\/bioinformatics\/btv359","volume":"31","author":"NT Gupta","year":"2015","unstructured":"Gupta, N. T. et al. Change-O: a toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data. Bioinformatics 31, 3356\u20133358 (2015).","journal-title":"Bioinformatics"},{"key":"3324_CR59","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41586-019-0934-8","volume":"566","author":"C Soto","year":"2019","unstructured":"Soto, C. et al. High frequency of shared clonotypes in human B cell receptor repertoires. Nature 566, 398\u2013402 (2019).","journal-title":"Nature"},{"key":"3324_CR60","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.3389\/fimmu.2019.02365","volume":"10","author":"Y Guo","year":"2019","unstructured":"Guo, Y., Chen, K., Kwong, P. D., Shapiro, L. & Sheng, Z. cAb-Rep: a database of curated antibody repertoires for exploring antibody diversity and predicting antibody prevalence. Front. Immunol. 10, 2365 (2019).","journal-title":"Front. Immunol."},{"key":"3324_CR61","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0022-2836(82)90515-0","volume":"157","author":"J Kyte","year":"1982","unstructured":"Kyte, J. & Doolittle, R. F. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157, 105\u2013132 (1982).","journal-title":"J. Mol. Biol."},{"key":"3324_CR62","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0006-3495(85)83877-7","volume":"47","author":"HR Guy","year":"1985","unstructured":"Guy, H. R. Amino acid side-chain partition energies and distribution of residues in soluble proteins. Biophys. J. 47, 61\u201370 (1985).","journal-title":"Biophys. J."},{"key":"3324_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0160853","volume":"11","author":"WS DeWitt","year":"2016","unstructured":"DeWitt, W. S. et al. A public database of memory and naive B-cell receptor sequences. PLoS ONE 11, e0160853 (2016).","journal-title":"PLoS ONE"},{"key":"3324_CR64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0049774","volume":"7","author":"F Rubelt","year":"2012","unstructured":"Rubelt, F. et al. Onset of immune senescence defined by unbiased pyrosequencing of human immunoglobulin mRNA repertoires. PLoS ONE 7, e49774 (2012).","journal-title":"PLoS ONE"},{"key":"3324_CR65","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1126\/science.abe2402","volume":"370","author":"A Baum","year":"2020","unstructured":"Baum, A. et al. REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters. Science 370, 1110\u20131115 (2020).","journal-title":"Science"},{"key":"3324_CR66","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1056\/NEJMoa2035002","volume":"384","author":"DM Weinreich","year":"2021","unstructured":"Weinreich, D. M. et al. REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19. N. Engl. J. Med. 384, 238\u2013251 (2021).","journal-title":"N. Engl. J. Med."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41586-021-03324-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41586-021-03324-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41586-021-03324-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T18:09:31Z","timestamp":1684606171000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-021-03324-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,10]]},"references-count":66,"journal-issue":{"issue":"7855","published-print":{"date-parts":[[2021,4,22]]}},"alternative-id":["3324"],"URL":"https:\/\/doi.org\/10.1038\/s41586-021-03324-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.01.15.426911","asserted-by":"object"}],"has-review":[{"id-type":"doi","id":"10.3410\/f.739524179.793585051","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,10]]},"assertion":[{"value":"15 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Rockefeller University has filed a provisional patent application in connection with this work, on which Z.W. and M.C.N. are inventors (US patent 63\/199, 676).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}